BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27926791)

  • 1. High prevalence of MiTF staining in undifferentiated pleomorphic sarcoma: caution in the use of melanocytic markers in sarcoma.
    Choy B; Hyjek E; Montag AG; Pytel P; Haydon R; Luu HH; Zhen CJ; Long BC; Kadri S; Segal JP; Furtado LV; Cipriani NA
    Histopathology; 2017 Apr; 70(5):734-745. PubMed ID: 27926791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microphthalmia-associated transcription factor (MiTF): Promiscuous staining patterns in fibrohistiocytic lesions is a potential pitfall.
    Mohanty SK; Sharma S; Pradhan D; Kandukuri SR; Farahani N; Barry C; Wu JM; Frishberg D; Balzer B
    Pathol Res Pract; 2018 Jun; 214(6):821-825. PubMed ID: 29773427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of melanocytic and myofibroblastic markers and their molecular correlation in atypical fibroxanthomas and pleomorphic dermal sarcomas.
    Helbig D; Mauch C; Buettner R; Quaas A
    J Cutan Pathol; 2018 Dec; 45(12):880-885. PubMed ID: 30155964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.
    Koch MB; Shih IM; Weiss SW; Folpe AL
    Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
    Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
    Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker.
    Agaimy A; Specht K; Stoehr R; Lorey T; Märkl B; Niedobitek G; Straub M; Hager T; Reis AC; Schilling B; Schneider-Stock R; Hartmann A; Mentzel T
    Am J Surg Pathol; 2016 Feb; 40(2):181-91. PubMed ID: 26448190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
    Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
    Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MITF positivity in atypical fibroxanthoma: a diagnostic pitfall.
    Tallon B; Beer TW
    Am J Dermatopathol; 2014 Nov; 36(11):888-91. PubMed ID: 25238448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas.
    Xu X; Chu AY; Pasha TL; Elder DE; Zhang PJ
    Am J Surg Pathol; 2002 Jan; 26(1):82-7. PubMed ID: 11756773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micropthalmia transcription factor (MITF) as a diagnostic marker for metastatic melanomas negative for other melanoma markers.
    Guo R; Franco-Palacios M; Russell M; Goddard L; Hassell L; Gillies E; Fung KM
    Int J Clin Exp Pathol; 2013; 6(8):1658-64. PubMed ID: 23923085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of eight melanocytic and neural crest-associated markers in a well-characterised series of 124 malignant peripheral nerve sheath tumours (MPNST): useful to distinguish MPNST from melanoma?
    Gaspard M; Lamant L; Tournier E; Valentin T; Rochaix P; Terrier P; Ranchere-Vince D; Coindre JM; Filleron T; Le Guellec S
    Histopathology; 2018 Dec; 73(6):969-982. PubMed ID: 30137667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: a clinicopathological and immunohistochemical study of 70 cases.
    Buonaccorsi JN; Prieto VG; Torres-Cabala C; Suster S; Plaza JA
    Am J Dermatopathol; 2014 Feb; 36(2):124-30. PubMed ID: 23782678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis.
    King R; Weilbaecher KN; McGill G; Cooley E; Mihm M; Fisher DE
    Am J Pathol; 1999 Sep; 155(3):731-8. PubMed ID: 10487831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens.
    Dorvault CC; Weilbaecher KN; Yee H; Fisher DE; Chiriboga LA; Xu Y; Chhieng DC
    Cancer; 2001 Oct; 93(5):337-43. PubMed ID: 11668469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of a melanoma in situ to a sarcomatoid dedifferentiated melanoma.
    Chung J; Shevchenko A; Lee JB
    J Cutan Pathol; 2021 Jul; 48(7):943-947. PubMed ID: 33675557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi.
    Lu S; Slominski A; Yang SE; Sheehan C; Ross J; Carlson JA
    J Cutan Pathol; 2010 Apr; 37 Suppl 1(Suppl 1):26-40. PubMed ID: 20482673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of benign and malignant melanocytic lesions of the conjunctiva using double-staining.
    Soon AK; Brownstein S; Tang T; Saleh S; Jiang K; Levac J; Blanco P; Farmer J
    Can J Ophthalmol; 2019 Dec; 54(6):699-707. PubMed ID: 31836103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MITF accurately highlights epidermal melanocytes in atypical intraepidermal melanocytic proliferations.
    Nybakken GE; Sargen M; Abraham R; Zhang PJ; Ming M; Xu X
    Am J Dermatopathol; 2013 Feb; 35(1):25-9. PubMed ID: 22668579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of immunostaining using pan-melanoma cocktail, SOX10, and microphthalmia transcription factor in confirming a diagnosis of melanoma on fine-needle aspiration smears.
    Clevenger J; Joseph C; Dawlett M; Guo M; Gong Y
    Cancer Cytopathol; 2014 Oct; 122(10):779-85. PubMed ID: 24954720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
    Orosz Z
    Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.